These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 33862148)

  • 1. Treatment with Non-specific HDAC Inhibitors Administered after Disease Onset does not Delay Evolution in a Mouse Model of Progressive Multiple Sclerosis.
    Buonvicino D; Ranieri G; Chiarugi A
    Neuroscience; 2021 Jun; 465():38-45. PubMed ID: 33862148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE.
    Levy Barazany H; Barazany D; Puckett L; Blanga-Kanfi S; Borenstein-Auerbach N; Yang K; Peron JP; Weiner HL; Frenkel D
    Exp Neurol; 2014 May; 255():63-70. PubMed ID: 24552689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune encephalomyelitis in NOD mice is not initially a progressive multiple sclerosis model.
    Baker D; Nutma E; O'Shea H; Cooke A; Orian JM; Amor S
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1362-1372. PubMed ID: 31402611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mitochondriogenic but not the immunosuppressant effects of mTOR inhibitors prompt neuroprotection and delay disease evolution in a mouse model of progressive multiple sclerosis.
    Buonvicino D; Pratesi S; Ranieri G; Pistolesi A; Guasti D; Chiarugi A
    Neurobiol Dis; 2024 Feb; 191():106387. PubMed ID: 38142841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis.
    Gilgun-Sherki Y; Panet H; Melamed E; Offen D
    Brain Res; 2003 Nov; 989(2):196-204. PubMed ID: 14556941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epigenetic drug Trichostatin A ameliorates experimental autoimmune encephalomyelitis via T cell tolerance induction and impaired influx of T cells into the spinal cord.
    Jayaraman A; Soni A; Prabhakar BS; Holterman M; Jayaraman S
    Neurobiol Dis; 2017 Dec; 108():1-12. PubMed ID: 28736194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inconsistence between number and function of autoreactive T cells in the course of experimental autoimmune encephalomyelitis.
    Wan X; Pei W; Zhang Y; Zhang L; Shahzad KA; Xu T; Shen C
    Immunol Invest; 2018 Jan; 47(1):1-17. PubMed ID: 28872930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
    Choi JH; Lee MJ; Jang M; Kim EJ; Shim I; Kim HJ; Lee S; Lee SW; Kim YO; Cho IH
    PLoS One; 2015; 10(10):e0138592. PubMed ID: 26444423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental Autoimmune Encephalomyelitis (EAE) Model of Cynomolgus Macaques Induced by Recombinant Human MOG1-125 (rhMOG1-125) Protein and MOG34-56 Peptide.
    Peng Z; Zhang L; Wang H; He X; Peng X; Zhang Q; Liu H; Rao J; Wang H; Wu J; Sun Y
    Protein Pept Lett; 2018 Feb; 24(12):1166-1178. PubMed ID: 29141529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis.
    Ge Z; Da Y; Xue Z; Zhang K; Zhuang H; Peng M; Li Y; Li W; Simard A; Hao J; Yao Z; Zhang R
    Exp Neurol; 2013 Mar; 241():56-66. PubMed ID: 23261766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
    Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
    Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroimmunological characterization of a mouse model of primary progressive experimental autoimmune encephalomyelitis and effects of immunosuppressive or neuroprotective strategies on disease evolution.
    Buonvicino D; Ranieri G; Pratesi S; Guasti D; Chiarugi A
    Exp Neurol; 2019 Dec; 322():113065. PubMed ID: 31536728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary investigation of phoshodiesterase 7 inhibitor VP3.15 as therapeutic agent for the treatment of experimental autoimmune encephalomyelitis mice.
    Martín-Álvarez R; Paúl-Fernández N; Palomo V; Gil C; Martínez A; Mengod G
    J Chem Neuroanat; 2017 Mar; 80():27-36. PubMed ID: 28007551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
    Mony JT; Khorooshi R; Owens T
    Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Expression in Spontaneous Experimental Autoimmune Encephalomyelitis Is Linked to Human Multiple Sclerosis Risk Genes.
    Faber H; Kurtoic D; Krishnamoorthy G; Weber P; Pütz B; Müller-Myhsok B; Weber F; Andlauer TFM
    Front Immunol; 2020; 11():2165. PubMed ID: 33072080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling.
    Zhang D; Qiao L; Fu T
    Biomed Pharmacother; 2020 May; 125():109528. PubMed ID: 32106388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA.
    Derdelinckx J; Mansilla MJ; De Laere M; Lee WP; Navarro-Barriuso J; Wens I; Nkansah I; Daans J; De Reu H; Jolanta Keliris A; Van Audekerke J; Vanreusel V; Pieters Z; Van der Linden A; Verhoye M; Molenberghs G; Hens N; Goossens H; Willekens B; Cras P; Ponsaerts P; Berneman ZN; Martínez-Cáceres EM; Cools N
    J Neuroinflammation; 2019 Aug; 16(1):167. PubMed ID: 31416452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational design and synthesis of altered peptide ligands based on human myelin oligodendrocyte glycoprotein 35-55 epitope: inhibition of chronic experimental autoimmune encephalomyelitis in mice.
    Tselios T; Aggelidakis M; Tapeinou A; Tseveleki V; Kanistras I; Gatos D; Matsoukas J
    Molecules; 2014 Nov; 19(11):17968-84. PubMed ID: 25375337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of an animal model of experimental autoimmune encephalomyelitis achieved with a multiple MOG(35-55)peptide in C57BL6/J strain of mice.
    Costa O; Divoux D; Ischenko A; Tron F; Fontaine M
    J Autoimmun; 2003 Feb; 20(1):51-61. PubMed ID: 12604312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.